tiprankstipranks
Trending News
More News >

Karydas Daphne Insider Profile

4 Followers
Karydas Daphne, Chief Financial Officer at Syndax Pharmaceuticals, holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in Logicbio Therapeutics (Ticker: ~LOGC), holds 0.00 shares in Mineralys Therapeutics, Inc. (Ticker: MLYS). Most recently, Karydas Daphne ― shares of Syndax Pharmaceuticals on ― for an estimated value of ―.
tipranks
Karydas Daphne

Karydas Daphne
Syndax Pharmaceuticals (SNDX)
Chief Financial Officer

Not Ranked
Karydas Daphne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Karydas Daphne does not currently own shares as a corporate insider.
A breakdown of Karydas Daphne's holdings

Insider Roles

Syndax Pharmaceuticals
(SNDX)
Chief Financial Officer
Mineralys Therapeutics, Inc.
(MLYS)
Director
COMPASS Pathways
(CMPS)
Director
Roles that Karydas Daphne holds in companies

Most Profitable Insider Trade

Stock:
Mineralys Therapeutics, Inc.
(MLYS)
Rating:Informative Sell
Date:Nov 13, 2025 - Today
Return:+7.70%
The most profitable trade made by Karydas Daphne

Karydas Daphne's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Syndax Pharmaceuticals
Chief Financial Officer
~LOGC
Logicbio Therapeutics
Mineralys Therapeutics, Inc.
Nov 13, 2025
Director
Uninformative Buy
153.00K
$0.00
COMPASS Pathways
Director
List of latest transactions for each holding click on a transaction to see Karydas Daphne's performance on stock

Karydas Daphne insider profile FAQ

What is the percentage of profitable transactions made by Karydas Daphne?
The percentage of profitable transactions made by Karydas Daphne is ―.
    What is the average return per transaction made by Karydas Daphne?
    The average return per transaction made by Karydas Daphne is ―.
      What stocks does Karydas Daphne hold?
      Karydas Daphne holds: SNDX, ~LOGC, MLYS, CMPS stocks.
        What was Karydas Daphne’s latest transaction?
        Karydas Daphne latest transaction was an Uninformative Buy of ―.
          What was Karydas Daphne's most profitable transaction?
          Karydas Daphne’s most profitable transaction was an Informative Sell of MLYS stock on November 13, 2025. The return on the trade was 7.70%.
            What is Karydas Daphne's role in Syndax Pharmaceuticals?
            Karydas Daphne's role in Syndax Pharmaceuticals is Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.